The drug development process typically consists of several key stages: Discovery, Preclinical Testing, Clinical Trials, Regulatory Approval, and Post-marketing Surveillance. Toxicological assessments are essential from the early discovery phase through to post-marketing to ensure the safety of the drug at every stage.
